Search for: "Merck & Company, Inc."
Results 281 - 300
of 446
Sort by Relevance
|
Sort by Date
20 Apr 2010, 5:07 pm
Many lawsuits have been filed against the pharmaceutical companies associated with the birth control product NUVARING® in the United States. [read post]
7 Apr 2010, 4:30 am
: The Medicines Company v Kappos (Peter Zura's 271 Patent Blog) Cancidas (Caspofungin) – US: District Court New Jersey: Merck & Co files patent infringement complaint following Para IV challenge by Sandoz (Patent Docs) Clarinex (Desloratadine) - US: Mass forfeiture of 180-day exclusivity! [read post]
6 Apr 2010, 8:50 am
In In re Omnicom Group, Inc. [read post]
25 Mar 2010, 12:51 pm
Boyko, Legal Director, Office of General Counsel, Merck & Co., Inc. [read post]
18 Mar 2010, 2:30 am
Amgen, Inc. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
26 Feb 2010, 4:17 pm
Merck & Co., Inc. et al; Simonian v. [read post]
17 Feb 2010, 5:10 am
Merck, Sharp & Dohme Corp. [read post]
2 Feb 2010, 1:20 pm
Inc. is the next Fosamax case set for trial in the federal court MDL, and this trial will start as scheduled on April 19, 2010. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
25 Jan 2010, 5:00 am
See Basic, Inc. v. [read post]
19 Jan 2010, 12:00 am
(Merck and Co. [read post]
7 Jan 2010, 10:36 am
Wyeth, Inc., 2007 WL 2458021 (E.D. [read post]
31 Dec 2009, 4:43 pm
------- Title: Merck & Co., Inc. v. [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi… [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi… [read post]
28 Dec 2009, 7:57 am
The case is still proceeding against Dey, Inc., Mylan Pharmaceuticals, Inc., Sandoz, Inc. and their parent companies. [read post]
16 Dec 2009, 2:51 pm
Together, the companies account for over 75 percent of all poultry vaccine sales in the United States. [read post]
15 Dec 2009, 11:32 pm
Merck & Co. agreed to pay $4.85 billion to resolve more than 48,000 claims over the withdrawn painkiller. [read post]
